Patents by Inventor Hae Youn KANG

Hae Youn KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition, kit, and method for diagnosis and treatment of taxane anticancer agent-resistant cancer
    Patent number: 11639531
    Abstract: According to a composition, kit, and method for diagnosing resistance to a taxane anticancer agent, a composition for treating taxane cancer agent-resistant cancers, and a method for screening materials for the same, taxane anticancer agent-resistant cancers may be efficiently diagnosed or treated, and candidate materials that may treat taxane anticancer agent-resistant cancers may be efficiently screened.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: May 2, 2023
    Assignee: SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hee Jung An, Tae Heon Kim, Hae Youn Kang
  • BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO IMMUNE THERAPEUTIC AGENT
    Publication number: 20230002833
    Abstract: The disclosure relates to biomarkers for predicting a therapeutic response of a patient to an immune therapy. Since gene signatures and markers according to an aspect have an excellent predictive capacity for predicting a patient's therapeutic response to an immune therapy, a patient group predicted to exhibit therapeutic effects may be selected to perform an appropriate treatment, and a patient's suffering and costs may be reduced.
    Type: Application
    Filed: November 10, 2020
    Publication date: January 5, 2023
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: So Hyun HWANG, Jae Joon LIM, Kwang Yul CHA, Hee Jung AN, Hae Youn KANG, Kyung Gi CHO, Jin Hyung HEO, Je-Gun JOUNG, Se Wha KIM, Ah Young KWON
  • COMPOSITION, KIT, AND METHOD FOR DIAGNOSIS AND TREATMENT OF TAXANE ANTICANCER AGENT-RESISTANT CANCER
    Publication number: 20220119888
    Abstract: According to a composition, kit, and method for diagnosing resistance to a taxane anticancer agent, a composition for treating taxane cancer agent-resistant cancers, and a method for screening materials for the same, taxane anticancer agent-resistant cancers may be efficiently diagnosed or treated, and candidate materials that may treat taxane anticancer agent-resistant cancers may be efficiently screened.
    Type: Application
    Filed: March 20, 2019
    Publication date: April 21, 2022
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hee Jung AN, Tae Heon KIM, Hae Youn KANG